Thomas O'Connor, PhD

Thomas O’Connor, Ph.D., is a director for process analytics in drug product development at GSK. His team at GSK develops models to accelerate process development and increase the robustness of commercial manufacturing. Tom is joining GSK from the FDA where he was the deputy director of the Office of Pharmaceutical Quality Research in the Center for Drug Evaluation and Research (CDER) and the vice-chair of CDER’s Emerging Technology Team (ETT). Tom was a recognized modeling leader at the FDA and served on the steering committees for both CDER’s AI Council and CDER’s Quantitative Medicine Center of Excellence. Prior to joining the FDA in 2013, he worked at ExxonMobil Research and Engineering where he held job functions in process analytics and process control. Tom earned a B.S. in chemical engineering from the Cooper Union and a Ph.D. in chemical engineering from Princeton University.